Vol.:(0123456789) 1 3
The International Journal of Cardiovascular Imaging
https://doi.org/10.1007/s10554-020-01877-7
ORIGINAL PAPER
Very late‑phase vascular response after everolimus‑eluting stent
implantation assessed by optical coherence tomography
Amir Kh. M. Khalifa
1
· Yasushi Ino
1
· Takashi Kubo
1
· Takashi Tanimoto
1
· Kunihiro Shimamura
1
·
Yasutsugu Shiono
1
· Masahiro Takahata
1
· Kosei Terada
1
· Daisuke Higashioka
1
· Teruaki Wada
1
· Akira Taruya
1
·
Hiroki Emori
1
· Yosuke Katayama
1
· Manabu Kashiwagi
1
· Akio Kuroi
1
· Yoshiki Matsuo
1
· Suwako Fujita
1
·
Atsushi Tanaka
1
· Takeshi Hozumi
1
· Takashi Akasaka
1
Received: 18 January 2020 / Accepted: 2 May 2020
© Springer Nature B.V. 2020
Abstract
Long-term safety of second generation drug-eluting stents (DES) has not yet been evaluated. We sought to evaluate the very
late phase (> 3 years) vascular response after second generation everolimus-eluting stent (EES) as compared with frst genera-
tion sirolimus-eluting stent (SES) by using optical coherence tomography (OCT). We examined the vascular response in 39
patients with a total of 55 DESs [31 EESs (mean 54 months after stenting) and 24 frst generation SES (mean 66 months after
stenting)] by OCT. The frequency of lesions with any malapposed stent struts (19% vs. 46%, p = 0.035) and evagination (6%
vs. 42%, p = 0.002) was signifcantly lower. Segments with malapposed stent struts were signifcantly shorter (0.4 ± 0.9 mm
vs. 1.9 ± 3.5 mm, p = 0.024), maximal malapposition area and malapposition volume were signifcantly smaller (0.26 ± 0.38
mm
2
vs. 0.95 ± 1.54 mm
2
, p = 0.019, and 0.78 ± 1.35 mm
3
vs. 6.22 ± 15.76 mm
3
, p = 0.016, respectively) in EES. Compared
with frst generation SES, second generation EES showed more favourable vascular responses at the very late phase.
Keywords Late vascular response · Optical coherence tomography · Everolimus-eluting stent · First generation drug-
eluting stent · Stent malapposition
Introduction
Drug-eluting stents (DES) have markedly reduced the mid-
term (< 12 months) incidence of angiographic restenosis and
target lesion revascularization (TLR) after stent implantation
in comparison with bare-metal stents (BMS) [1, 2]. How-
ever, late-phase clinical events, including late stent thrombo-
sis and delayed restenosis, termed as late DES failure, have
been proposed as potential concerns after frst generation
DES implantation [3, 4]. Several pathological and optical
coherence tomography (OCT) studies have demonstrated
that delayed arterial healing with poor strut coverage and/or
strut malapposition have been identifed as major substrate
responsible for late and very late stent thrombosis (LST/
VLST) after frst generation sirolimus-eluting stent (SES)
[5–8]. Furthermore, previous studies have demonstrated
that atherogenic changes within the neointima after stent
implantation, termed as neoatherosclerosis (NA), is one of
the major causes of late DES failure [9–12]. Several studies
also suggested that chronic infammation, which induced by
polymers of DES, develops delayed arterial healing and NA
within frst generation DES-treated lesion and contributes
toward late DES failure [6–10].
Compared with the frst-generation DES, the second-gen-
eration DES, such as the everolimus-eluting stent (EES),
have been developed to improve the safety profle by means
of more biocompatible polymers, reduced drug dose with
adapted release kinetics, and reduced strut thickness [13,
14]. These enhanced properties may diminish development
of delayed arterial healing and NA. Some clinical trials
demonstrated the superior efcacy and safety of EES within
3 years after stent implantation compared with frst genera-
tion DES [13, 15]. However, long-term safety of EES has
not yet been evaluated. We therefore evaluated the very late
phase (> 3 years) vascular response after second-generation
EES as compared with frst generation SES by using OCT.
* Yasushi Ino
yasushi470923@yahoo.co.jp
1
Department of Cardiovascular Medicine, Wakayama
Medical University, 811-1 Kimiidera, Wakayama 641-8509,
Japan